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To the Editor, 
Multiple myeloma is a disorder in which malignant plasma 
cells, generally derived from one clone, accumulate in the bone 
marrow [1]. Electrophoresis of plasma proteins is used as a 
diagnostic test for this disorder [2,3]. In rare conditions, electro-
phoresis produces more than one narrow peak simultaneously, 
suggesting the existence of more than one clonal antibody and 
establishing a biclonal, triclonal or oligoclonal gammopathy [3].
A 56-year-old male was referred to our hospital in 
September 2005 with low-back pain. The physical examination 
was normal, except for muscle weakness of the bilateral lower 
extremities. The laboratory examination findings were as fol-
lows: hemoglobin 11.8 g/dl, white cell count 3.8x109 /L, eryth-
rocyte sedimentation rate 102 mm/h and globulin 2.7 g/dl. 
Serum IgG was 3.98 g/dl (7-16), IgA 9.7 g/dl (0.7-4), IgM 0.43 
g/dl (0.4-2.3), lambda light chain 3.94 g/L (0.9-2.1), and kappa 
light chain 1.25 g/L (1.7-3.78). Serum protein electrophoresis 
showed four clonal bands on the gamma region. Capillary 
immunofixation of the serum revealed the presence of IgA 
lambda oligoclonal gammopathy (Figure 1). The liver and kid-
ney functions were normal. X-ray films of the bones revealed 
lytic areas in the skull, pelvis and the ribs. Bone marrow aspira-
tion showed hypercellularity with approximately 30% infiltration 
of low differentiated plasma cells. Informed consent was 
obtained from the patient.
A homogeneous spike-like peak in a focal region of the 
gamma-globulin zone indicates a monoclonal gammopathy. 
Both neoplastic and non-neoplastic disorders are associated 
with monoclonal paraproteinemia [4]. Biclonal gammopathy is 
associated with similar disorders [5]. The distribution between 
various clinical entities, the clinical features of the patients as 
well as the prognosis seem to be similar to those of monoclo-
nal gammopathies [6]. In contrast, polyclonal gammopathies 
may be caused by any reactive or inflammatory process [7]. 
They are characterized by a broad diffuse band with one or 
more heavy chains and kappa and lambda light chains. Protein 
electrophoresis is extremely valuable for recognizing cases of 
Figure 1. Capillary immunofixation of the serum revealed the presence of IgA 
lambda oligoclonal gammopathy (arrow)
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126 Letter to the Editormonoclonal gammopathies and for following quantitative 
changes in spikes. M-proteins appear as tall, narrow, sharply 
defined peaks that reflect their structural homogeneity. They 
are usually located in the a or a-` region. IgA spikes are usu-
ally broader, as seen in our case, because the molecule tends 
to form polymers of different sizes (4). The prevalence of mono 
and biclonal gammopathies in the general population ranges 
between 1-3%, but only 1% of these are biclonal [3]. 
In conclusion, our case is the first report of multiple myeloma 
that is derived from four clones. Immunoelectrophoresis showed 
that all four clones included the same heavy and light chain. 
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